UbcH10 expression may be a useful tool in the prognosis of ovarian carcinomas

Oncogene

Volumn 26, Issue 14, 2007, Pages 2136-2140

  Berlingieri, M T ^a   Pallante, P ^a   Guida, M ^b   Nappi, C ^b   Masciullo, V ^c   Scambia, G ^c   Ferraro, A ^d   Leone, V ^d   Sboner, A ^e   Barbareschi, M ^f   Ferro, A ^f   Troncone, G ^a   Fusco, A ^a,d,g  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

^d CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

^e ITC IRST   (Italy)

^f SANTA CHIARA HOSPITAL   (Italy)

^g UNIVERSITY OF CHIETI   (Italy)

Author keywords

Carcinomas; Immunohistochemistry; Ovarian; UbcH10

Indexed keywords

RNA;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MARKER GENE; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RNA INTERFERENCE; STATISTICAL SIGNIFICANCE; UBCH10 GENE; UPREGULATION;

CARCINOMA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; OVARIAN NEOPLASMS; PROGNOSIS; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; UBIQUITIN-CONJUGATING ENZYMES; UP-REGULATION;

EID: 34047173492     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210010     Document Type: Article

References (17)

1. Aldovini D, Demichelis F, Doglioni C, Di Vizio D, Galligioni E, Brugnara S et al. (2006). M-CAM expression as marker of poor prognosis in epithelial ovarian cancer. Int J Cancer Jun 27 [Epub ahead of print].
2. Benedet JL, Bender H, Jones III H, Ngan HY, Pecorelli S. (2000). FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet 70: 209-262.
3. Feki A, Irminger-Finger I. (2004). Mutational spectrum of p53 mutations in primary breast and ovarian tumors. Crit Rev Oncol Hematol 52: 103-116.
4. Hershko A, Ciechanover A. (1998). The ubiquitin system. Annu Rev Biochem 67: 425-479.
5. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A et al. (2005). Cancer statistics, 2005. CA Cancer J Clin 55: 10-30.
6. Joazeiro CA, Weissman AM. (2000). Ring finger proteins: mediators of ubiquitin ligase activity. Cell 1 102: 549-552.
7. Liu X, Minin V, Huang Y, Seligson DB, Horvath S. (2004). Statistical methods for analysing tissue microarray data. J Biopharm Stat 14: 671-685.
8. Masciullo V, Baldassarre G, Pentimalli F, Berlingieri MT, Boccia A, Chiappetta G et al. (2003). HMGA1 protein overexpression is a frequent feature of epithelial ovarian carcinomas. Carcinogenesis 24: 1191-1198.
9. Ozols RF, Bookman MA, Connolly DC, Daly MB, Godwin AK, Schilder RJ et al. (2004). Focus on epithelial ovarian cancer. Cancer Cell 5: 19-24.
10. Pallante P, Berlingieri MT, Troncone G, Kruhoffer M, Orntoft TF, Viglietto G et al. (2005). UbcH10 overexpression may represent a marker of anaplastic thyroid carcinomas. Br J Cancer 93: 464-471.
11. Pierantoni GM, Rinaldo C, Esposito F, Mottolese M, Soddu S, Fusco A. (2005). High Mobility Group A1 (HMGA1) proteins interact with p53 and inhibit its apoptotic activity. Cell Death Differ (9 December): 1-10 (Epub ahead of print).
12. R Development Core Team (2004). A Language and Environment for Statistical Computing. R Foundation for Statistical Computing: Vienna, Austria.
13. Tavassoli FA, Devilee P. (2003). World Health Oraganization Classification of Tumours. Tumours of the breast and female genital organs. IARC Press: Lyon.
14. Troncone G, Iaccarino A, Caleo A, Bifano D, Pettinato G, Palombini L. (2003). p27 Kip1 protein expression in Hashimoto's thyroiditis. J Clin Pathol 56: 587-591.
15. Vacher-Lavenu MC, Le Tourneau A, Duvillard P, Godefroy N, Pinel MC. (1993). Pathological classification and grading of primary ovarian carcinoma: experience of the ARTAC ovarian study group. Bull Cancer 80: 135-141.
16. Wagner KW, Sapinoso LM, El-Rifai W, Frierson HF, Butz N, Mestan J et al. (2004). Overexpression, genomic amplification and therapeutic potential of inhibiting the UbcH10 ubiquitin conjugase in human carcinomas of diverse anatomic origin. Oncogene 23: 6621-6629.
17. Welcsh PL, King MC. (2001). BRCA1 and BRCA2 and the genetics of breast and ovarian cancer. Hum Mol Genet 10: 705-713.